EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations

Jessica Desjardins, Julian Bowlan, Cynthia Bernier, Srishti Jain, Théo Goullet de Rugy, David Gallo, Mark E Orcholski, Nancy Laterreur, Abira Rajah, Joshua Miller, Jennifer Lafontaine, Vivek Bhaskaran und 13 weitere

Cell Reports · 2026-09 · 45 (9) · 117961

DOI: 10.1016/j.celrep.2026.117961 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-09. Verfasst von Jessica Desjardins und 24 weiteren Autor:innen. Beteiligte Einrichtung: Repare Therapeutics, Saint-Laurent, QC, Canada. Hauptthemen laut MEDLINE: Neoplasms, Synthetic Lethal Mutations, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic lethality (SL) provides a treatment paradigm for targeting cancer with alterations in driver genes that are not conventionally druggable, including tumor suppressor genes. We execute a series of genome-wide CRISPR screens using functionally validated isogenic cell lines and conduct a large-scale SL analysis using data from the cancer dependency map (DepMap). We chart SL interactions across 15 driver alterations: FBXW7, CCNE1, CDK12, ARID1A, KMT2D, DNMT3A, TET2, KEAP1, STK11, IDH1, SF3B1, SRSF2, U2AF1, chromosome 18q loss, and chromosome 13q loss. We show validation of several SL interactions, including ARID1A and the hexosamine biosynthetic pathway aminotransferase GFPT1, STK11 with CAMK protein kinase MARK2, FBXW7 and the CDK1 regulatory kinase PKMYT1, and CCNE1 amplification and the anaphase-promoting complex or cyclosome (APC/C). In summary, this study offers a rich resource of genetic interactions across cancer drivers enabling the discovery of biological insights and drug targets for future therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsSynthetic Lethal MutationsClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsHumansCell Line, Tumor

Stichwörter der Autor:innen

CP: cancerCP: genomicsCRISPR screeningcancer driver mutationscancer therapeuticsdrug developmentfunctional genomicsgene dependencygenetic vulnerabilitiesgenome-wide knockoutoncogene addictionpersonalized medicineprecision oncologysynthetic lethalitytarget discovery

Autor:innen und Institutionen

  • Repare Therapeutics, Saint-Laurent, QC, Canada.
  • Repare Therapeutics, Cambridge, MA, USA.
  • Repare Therapeutics, Saint-Laurent, QC, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Repare Therapeutics, Saint-Laurent, QC, Canada. Electronic address: aaquilon@dcxbio.com.
  • Repare Therapeutics, Saint-Laurent, QC, Canada. Electronic address: jordan.young@astrazeneca.com.

Zitieren

APA

Desjardins, J., Bowlan, J., Bernier, C., Jain, S., Goullet de Rugy, T., Gallo, D., Orcholski, M. E., Laterreur, N., Rajah, A., Miller, J., Lafontaine, J., Bhaskaran, V., Li, L., Ling, A., Leblanc, J. H., Mathieu, M. C., Zinda, M., Morris, S. J., Durocher, D., …, & Young, J. T. F. (2026). Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations. Cell Reports, 45(9), 117961. https://doi.org/10.1016/j.celrep.2026.117961

Vancouver

Desjardins J, Bowlan J, Bernier C, Jain S, Goullet de Rugy T, Gallo D, et al. Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations. Cell Reports. 2026;45(9):117961. doi:10.1016/j.celrep.2026.117961

BibTeX
@article{Desjardins2026,
  author = {Desjardins, Jessica and Bowlan, Julian and Bernier, Cynthia and Jain, Srishti and Goullet de Rugy, Théo and Gallo, David and Orcholski, Mark E and Laterreur, Nancy and Rajah, Abira and Miller, Joshua and Lafontaine, Jennifer and Bhaskaran, Vivek and Li, Li and Ling, Alexanda and Leblanc, Jesse H and Mathieu, Marie-Claude and Zinda, Michael and Morris, Stephen J and Durocher, Daniel and Zimmermann, Michal and Roulston, Anne and Veloso, Artur and Fiore, Chris and Álvarez-Quilón, Alejandro and Young, Jordan T F},
  title = {Genome-wide CRISPR screens map synthetic lethal interactions across recurrent cancer driver alterations},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {9},
  pages = {117961},
  doi = {10.1016/j.celrep.2026.117961}
}
Kostenlos starten →